Similarly, we detected increased YKL-40 in the brain of an AD mouse model and in experimental models of prion diseases at pre-clinical stages, supporting the presence of astrocytic alterations before clinical onset and the usefulness of YKL-40 quantification in the detection of early pathological changes associated with neuroinflammation. Here, CHI3L1 is linked to prion disease.